No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
NeuVax is a cancer vaccine that is designed to target and stimulate the body's immune system to recognize and attack cancer cells. It is a personalized immunotherapy that is tailored to the individual patient's tumor profile. NeuVax is designed to target the HER2/neu antigen, which is overexpressed in many types of cancer, including breast, ovarian, and gastric cancers. It is administered as a series of injections, and is intended to be used in combination with other treatments such as chemotherapy and radiation.
NeuVax is a relatively new technology, and is still in the early stages of development. Clinical trials are ongoing to evaluate its safety and efficacy. The potential of NeuVax to provide a personalized approach to cancer treatment has generated considerable interest in the medical community.
Some companies in the NeuVax market include Galena Biopharma, ImmunoCellular Therapeutics, and OncoSec Medical. Show Less Read more
